nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.217	1	CrCrCtD
Estramustine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0815	0.215	CbGbCtD
Estramustine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0551	0.145	CbGbCtD
Estramustine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0525	0.139	CbGbCtD
Estramustine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0468	0.124	CbGbCtD
Estramustine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0458	0.121	CbGbCtD
Estramustine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0433	0.114	CbGbCtD
Estramustine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0275	0.0726	CbGbCtD
Estramustine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0259	0.0685	CbGbCtD
Estramustine—Glucose tolerance decreased—Arformoterol—chronic obstructive pulmonary disease	0.0124	0.053	CcSEcCtD
Estramustine—Glucose tolerance decreased—Formoterol—chronic obstructive pulmonary disease	0.0124	0.053	CcSEcCtD
Estramustine—MAP1A—bronchus—chronic obstructive pulmonary disease	0.00974	0.12	CbGeAlD
Estramustine—MAP1A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00953	0.117	CbGeAlD
Estramustine—MAP1A—trachea—chronic obstructive pulmonary disease	0.00874	0.107	CbGeAlD
Estramustine—Hoarseness—Tiotropium—chronic obstructive pulmonary disease	0.00703	0.03	CcSEcCtD
Estramustine—MAP2—respiratory system—chronic obstructive pulmonary disease	0.00672	0.0826	CbGeAlD
Estramustine—MAP1A—lung—chronic obstructive pulmonary disease	0.00628	0.0772	CbGeAlD
Estramustine—Throat irritation—Tiotropium—chronic obstructive pulmonary disease	0.00613	0.0261	CcSEcCtD
Estramustine—MAP2—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00605	0.0741	CbGpPWpGaD
Estramustine—MAP2—bronchus—chronic obstructive pulmonary disease	0.00553	0.068	CbGeAlD
Estramustine—Hoarseness—Salbutamol—chronic obstructive pulmonary disease	0.00536	0.0228	CcSEcCtD
Estramustine—MAP2—trachea—chronic obstructive pulmonary disease	0.00497	0.0611	CbGeAlD
Estramustine—Throat irritation—Arformoterol—chronic obstructive pulmonary disease	0.00494	0.0211	CcSEcCtD
Estramustine—Throat irritation—Formoterol—chronic obstructive pulmonary disease	0.00494	0.0211	CcSEcCtD
Estramustine—Glucose tolerance decreased—Prednisone—chronic obstructive pulmonary disease	0.00489	0.0209	CcSEcCtD
Estramustine—Hypercalcaemia—Aminophylline—chronic obstructive pulmonary disease	0.00472	0.0201	CcSEcCtD
Estramustine—MAP2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00469	0.0575	CbGpPWpGaD
Estramustine—Throat irritation—Salbutamol—chronic obstructive pulmonary disease	0.00467	0.0199	CcSEcCtD
Estramustine—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.0044	0.0188	CcSEcCtD
Estramustine—MAP2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.00439	0.0539	CbGpPWpGaD
Estramustine—ESR2—respiratory system—chronic obstructive pulmonary disease	0.00436	0.0535	CbGeAlD
Estramustine—Thromboembolism—Prednisolone—chronic obstructive pulmonary disease	0.00425	0.0181	CcSEcCtD
Estramustine—ESR2—connective tissue—chronic obstructive pulmonary disease	0.00384	0.0471	CbGeAlD
Estramustine—Dysphonia—Tiotropium—chronic obstructive pulmonary disease	0.00376	0.016	CcSEcCtD
Estramustine—MAP2—lung—chronic obstructive pulmonary disease	0.00357	0.0439	CbGeAlD
Estramustine—ESR2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00351	0.0431	CbGeAlD
Estramustine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00325	0.0399	CbGpPWpGaD
Estramustine—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00313	0.0134	CcSEcCtD
Estramustine—Thromboembolism—Prednisone—chronic obstructive pulmonary disease	0.00309	0.0132	CcSEcCtD
Estramustine—Dysphonia—Arformoterol—chronic obstructive pulmonary disease	0.00303	0.0129	CcSEcCtD
Estramustine—Dysphonia—Formoterol—chronic obstructive pulmonary disease	0.00303	0.0129	CcSEcCtD
Estramustine—ESR1—respiratory system—chronic obstructive pulmonary disease	0.00298	0.0367	CbGeAlD
Estramustine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00288	0.0353	CbGpPWpGaD
Estramustine—Dysphonia—Salbutamol—chronic obstructive pulmonary disease	0.00286	0.0122	CcSEcCtD
Estramustine—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00274	0.0117	CcSEcCtD
Estramustine—Embolism venous—Prednisolone—chronic obstructive pulmonary disease	0.00268	0.0114	CcSEcCtD
Estramustine—ESR1—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.00268	0.0328	CbGpPWpGaD
Estramustine—ESR1—connective tissue—chronic obstructive pulmonary disease	0.00263	0.0323	CbGeAlD
Estramustine—Hypernatraemia—Prednisolone—chronic obstructive pulmonary disease	0.00257	0.011	CcSEcCtD
Estramustine—ESR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.0024	0.0295	CbGeAlD
Estramustine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00235	0.0288	CbGpPWpGaD
Estramustine—ESR2—lung—chronic obstructive pulmonary disease	0.00231	0.0284	CbGeAlD
Estramustine—Cramps of lower extremities—Formoterol—chronic obstructive pulmonary disease	0.00229	0.00978	CcSEcCtD
Estramustine—Cramps of lower extremities—Arformoterol—chronic obstructive pulmonary disease	0.00229	0.00978	CcSEcCtD
Estramustine—ESR1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00223	0.0274	CbGpPWpGaD
Estramustine—Cramps of lower extremities—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00923	CcSEcCtD
Estramustine—Embolism—Prednisolone—chronic obstructive pulmonary disease	0.00211	0.00898	CcSEcCtD
Estramustine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00207	0.00881	CcSEcCtD
Estramustine—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.00206	0.00878	CcSEcCtD
Estramustine—ESR1—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.00203	0.0249	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Arformoterol—chronic obstructive pulmonary disease	0.002	0.00852	CcSEcCtD
Estramustine—Cardiac failure congestive—Formoterol—chronic obstructive pulmonary disease	0.002	0.00852	CcSEcCtD
Estramustine—Embolism venous—Prednisone—chronic obstructive pulmonary disease	0.00195	0.0083	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00193	0.0236	CbGpPWpGaD
Estramustine—Hypernatraemia—Prednisone—chronic obstructive pulmonary disease	0.00187	0.00797	CcSEcCtD
Estramustine—Thirst—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00795	CcSEcCtD
Estramustine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00182	0.00778	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00174	0.0213	CbGpPWpGaD
Estramustine—Affect lability—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00718	CcSEcCtD
Estramustine—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00708	CcSEcCtD
Estramustine—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00708	CcSEcCtD
Estramustine—ESR1—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00162	0.0199	CbGpPWpGaD
Estramustine—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00691	CcSEcCtD
Estramustine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00159	0.00677	CcSEcCtD
Estramustine—ESR1—lung—chronic obstructive pulmonary disease	0.00158	0.0195	CbGeAlD
Estramustine—Embolism—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00653	CcSEcCtD
Estramustine—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00153	0.00652	CcSEcCtD
Estramustine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00152	0.0065	CcSEcCtD
Estramustine—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00621	CcSEcCtD
Estramustine—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00587	CcSEcCtD
Estramustine—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00587	CcSEcCtD
Estramustine—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00584	CcSEcCtD
Estramustine—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00584	CcSEcCtD
Estramustine—Estropipate—CYP1A2—chronic obstructive pulmonary disease	0.00127	0.176	CrCbGaD
Estramustine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00519	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00121	0.0148	CbGpPWpGaD
Estramustine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.0012	0.00512	CcSEcCtD
Estramustine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00119	0.0146	CbGpPWpGaD
Estramustine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.00118	0.0145	CbGeAlD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00117	0.0143	CbGpPWpGaD
Estramustine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00491	CcSEcCtD
Estramustine—MAP2—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	0.00113	0.0139	CbGpPWpGaD
Estramustine—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.00483	CcSEcCtD
Estramustine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.00476	CcSEcCtD
Estramustine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00111	0.00476	CcSEcCtD
Estramustine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.00472	CcSEcCtD
Estramustine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00471	CcSEcCtD
Estramustine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00471	CcSEcCtD
Estramustine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00471	CcSEcCtD
Estramustine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0011	0.00469	CcSEcCtD
Estramustine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00468	CcSEcCtD
Estramustine—ESR1—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.00109	0.0134	CbGpPWpGaD
Estramustine—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00461	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00107	0.0131	CbGpPWpGaD
Estramustine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00451	CcSEcCtD
Estramustine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00447	CcSEcCtD
Estramustine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00447	CcSEcCtD
Estramustine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.00444	CcSEcCtD
Estramustine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00438	CcSEcCtD
Estramustine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00434	CcSEcCtD
Estramustine—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00433	CcSEcCtD
Estramustine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000998	0.00426	CcSEcCtD
Estramustine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00099	0.00422	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000966	0.0119	CbGpPWpGaD
Estramustine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000965	0.00412	CcSEcCtD
Estramustine—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000937	0.004	CcSEcCtD
Estramustine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000933	0.00398	CcSEcCtD
Estramustine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000929	0.00396	CcSEcCtD
Estramustine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000929	0.00396	CcSEcCtD
Estramustine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000929	0.00396	CcSEcCtD
Estramustine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000925	0.00395	CcSEcCtD
Estramustine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000925	0.00395	CcSEcCtD
Estramustine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000915	0.0112	CbGpPWpGaD
Estramustine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000906	0.00387	CcSEcCtD
Estramustine—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000899	0.00384	CcSEcCtD
Estramustine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00089	0.0038	CcSEcCtD
Estramustine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00089	0.0038	CcSEcCtD
Estramustine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000877	0.00374	CcSEcCtD
Estramustine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000874	0.00373	CcSEcCtD
Estramustine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000872	0.00372	CcSEcCtD
Estramustine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000871	0.0107	CbGeAlD
Estramustine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000854	0.00364	CcSEcCtD
Estramustine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000841	0.00359	CcSEcCtD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—NOS3—chronic obstructive pulmonary disease	0.000835	0.0102	CbGpPWpGaD
Estramustine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000828	0.00353	CcSEcCtD
Estramustine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000823	0.00351	CcSEcCtD
Estramustine—Estrone—CYP1A1—chronic obstructive pulmonary disease	0.000821	0.114	CrCbGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000813	0.00996	CbGpPWpGaD
Estramustine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000805	0.00343	CcSEcCtD
Estramustine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000805	0.00343	CcSEcCtD
Estramustine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000801	0.00342	CcSEcCtD
Estramustine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.0008	0.00341	CcSEcCtD
Estramustine—Conjugated Estrogens—CYP1A2—chronic obstructive pulmonary disease	0.000794	0.11	CrCbGaD
Estramustine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000794	0.00339	CcSEcCtD
Estramustine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000794	0.00339	CcSEcCtD
Estramustine—Estrone—CYP1A2—chronic obstructive pulmonary disease	0.000792	0.11	CrCbGaD
Estramustine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000789	0.00336	CcSEcCtD
Estramustine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000786	0.00335	CcSEcCtD
Estramustine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00078	0.00333	CcSEcCtD
Estramustine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00076	0.00324	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.000751	0.00921	CbGpPWpGaD
Estramustine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000749	0.0032	CcSEcCtD
Estramustine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000745	0.00318	CcSEcCtD
Estramustine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000744	0.00317	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000743	0.00911	CbGpPWpGaD
Estramustine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000741	0.00316	CcSEcCtD
Estramustine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000737	0.00315	CcSEcCtD
Estramustine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000737	0.00314	CcSEcCtD
Estramustine—Estropipate—ALB—chronic obstructive pulmonary disease	0.000734	0.102	CrCbGaD
Estramustine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000733	0.00313	CcSEcCtD
Estramustine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000731	0.00312	CcSEcCtD
Estramustine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000727	0.0031	CcSEcCtD
Estramustine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000713	0.00304	CcSEcCtD
Estramustine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00071	0.0087	CbGpPWpGaD
Estramustine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000702	0.00299	CcSEcCtD
Estramustine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000701	0.00299	CcSEcCtD
Estramustine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000695	0.00297	CcSEcCtD
Estramustine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000695	0.00296	CcSEcCtD
Estramustine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000695	0.00296	CcSEcCtD
Estramustine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000691	0.00295	CcSEcCtD
Estramustine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000678	0.00289	CcSEcCtD
Estramustine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000675	0.00288	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000671	0.00822	CbGpPWpGaD
Estramustine—ESR2—Plasma membrane estrogen receptor signaling—MMP9—chronic obstructive pulmonary disease	0.00067	0.00821	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000659	0.00808	CbGpPWpGaD
Estramustine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000655	0.00279	CcSEcCtD
Estramustine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000653	0.00279	CcSEcCtD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000632	0.00776	CbGpPWpGaD
Estramustine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00063	0.00269	CcSEcCtD
Estramustine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00063	0.00269	CcSEcCtD
Estramustine—ABCB1—lung—chronic obstructive pulmonary disease	0.000626	0.00769	CbGeAlD
Estramustine—Estradiol—CYP1A1—chronic obstructive pulmonary disease	0.000622	0.0862	CrCbGaD
Estramustine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000617	0.00263	CcSEcCtD
Estramustine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000617	0.00756	CbGpPWpGaD
Estramustine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000609	0.0026	CcSEcCtD
Estramustine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000609	0.0026	CcSEcCtD
Estramustine—ESR1—Regulation of Telomerase—HDAC2—chronic obstructive pulmonary disease	0.000601	0.00737	CbGpPWpGaD
Estramustine—Estradiol—CYP1A2—chronic obstructive pulmonary disease	0.0006	0.0831	CrCbGaD
Estramustine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000597	0.00254	CcSEcCtD
Estramustine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000595	0.00254	CcSEcCtD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000594	0.00729	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.00059	0.00724	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000589	0.00722	CbGpPWpGaD
Estramustine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000575	0.00245	CcSEcCtD
Estramustine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000567	0.00242	CcSEcCtD
Estramustine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000566	0.00241	CcSEcCtD
Estramustine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000566	0.00241	CcSEcCtD
Estramustine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000561	0.00239	CcSEcCtD
Estramustine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000561	0.00239	CcSEcCtD
Estramustine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000561	0.00688	CbGpPWpGaD
Estramustine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000561	0.00239	CcSEcCtD
Estramustine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000561	0.00239	CcSEcCtD
Estramustine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000558	0.00238	CcSEcCtD
Estramustine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000558	0.00238	CcSEcCtD
Estramustine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000554	0.00236	CcSEcCtD
Estramustine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00055	0.00235	CcSEcCtD
Estramustine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000549	0.00234	CcSEcCtD
Estramustine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000548	0.00234	CcSEcCtD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000548	0.00671	CbGpPWpGaD
Estramustine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000546	0.00233	CcSEcCtD
Estramustine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000541	0.00231	CcSEcCtD
Estramustine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000538	0.0023	CcSEcCtD
Estramustine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000537	0.00659	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000535	0.00657	CbGpPWpGaD
Estramustine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000534	0.00228	CcSEcCtD
Estramustine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00053	0.00226	CcSEcCtD
Estramustine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00226	CcSEcCtD
Estramustine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000529	0.00226	CcSEcCtD
Estramustine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000529	0.00226	CcSEcCtD
Estramustine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000527	0.00225	CcSEcCtD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000523	0.00641	CbGpPWpGaD
Estramustine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000518	0.00221	CcSEcCtD
Estramustine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000516	0.00632	CbGpPWpGaD
Estramustine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000499	0.00213	CcSEcCtD
Estramustine—Testosterone—CYP1A1—chronic obstructive pulmonary disease	0.000499	0.0692	CrCbGaD
Estramustine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000496	0.00608	CbGpPWpGaD
Estramustine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000482	0.00206	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000465	0.0057	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000459	0.00563	CbGpPWpGaD
Estramustine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000458	0.00195	CcSEcCtD
Estramustine—Estrone—ALB—chronic obstructive pulmonary disease	0.000457	0.0634	CrCbGaD
Estramustine—ESR1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.00045	0.00552	CbGpPWpGaD
Estramustine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000448	0.00549	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000445	0.00546	CbGpPWpGaD
Estramustine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.00186	CcSEcCtD
Estramustine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000436	0.00186	CcSEcCtD
Estramustine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00043	0.00527	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000426	0.00522	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—NOS3—chronic obstructive pulmonary disease	0.000421	0.00516	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000411	0.00505	CbGpPWpGaD
Estramustine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000408	0.005	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000396	0.00486	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000391	0.0048	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000378	0.00464	CbGpPWpGaD
Estramustine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000375	0.00459	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000371	0.00456	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.00037	0.00454	CbGpPWpGaD
Estramustine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000364	0.00155	CcSEcCtD
Estramustine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00036	0.00442	CbGpPWpGaD
Estramustine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00035	0.00149	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—LEP—chronic obstructive pulmonary disease	0.000347	0.00425	CbGpPWpGaD
Estramustine—Estradiol—ALB—chronic obstructive pulmonary disease	0.000346	0.048	CrCbGaD
Estramustine—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000342	0.00419	CbGpPWpGaD
Estramustine—ESR1—Plasma membrane estrogen receptor signaling—MMP9—chronic obstructive pulmonary disease	0.000338	0.00414	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000337	0.00414	CbGpPWpGaD
Estramustine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000334	0.00142	CcSEcCtD
Estramustine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000317	0.00135	CcSEcCtD
Estramustine—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000314	0.00386	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000312	0.00382	CbGpPWpGaD
Estramustine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000305	0.0013	CcSEcCtD
Estramustine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.0013	CcSEcCtD
Estramustine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.0013	CcSEcCtD
Estramustine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000302	0.00129	CcSEcCtD
Estramustine—ESR1—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.000294	0.0036	CbGpPWpGaD
Estramustine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.00122	CcSEcCtD
Estramustine—ESR1—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000279	0.00342	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000278	0.00341	CbGpPWpGaD
Estramustine—Testosterone—ALB—chronic obstructive pulmonary disease	0.000278	0.0385	CrCbGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	0.000277	0.00339	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000265	0.00325	CbGpPWpGaD
Estramustine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000265	0.00325	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.00026	0.00319	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	0.00026	0.00318	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000256	0.00314	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000254	0.00312	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.00025	0.00306	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	0.000249	0.00305	CbGpPWpGaD
Estramustine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00106	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000244	0.00299	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	0.000243	0.00298	CbGpPWpGaD
Estramustine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00024	0.00102	CcSEcCtD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	0.000237	0.00291	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000229	0.00281	CbGpPWpGaD
Estramustine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00095	CcSEcCtD
Estramustine—ESR1—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	0.000221	0.00271	CbGpPWpGaD
Estramustine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000942	CcSEcCtD
Estramustine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000941	CcSEcCtD
Estramustine—ESR1—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	0.000221	0.0027	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	0.00022	0.0027	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.00022	0.0027	CbGpPWpGaD
Estramustine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000936	CcSEcCtD
Estramustine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000219	0.00269	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.00263	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000214	0.00262	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000211	0.00259	CbGpPWpGaD
Estramustine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000888	CcSEcCtD
Estramustine—ESR2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000206	0.00253	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000205	0.00251	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000204	0.0025	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000203	0.00249	CbGpPWpGaD
Estramustine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00236	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000189	0.00232	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	0.000186	0.00228	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	0.000182	0.00223	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	0.000181	0.00222	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000177	0.00217	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000176	0.00215	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000174	0.00213	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000161	0.00198	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000159	0.00195	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000158	0.00194	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000157	0.00192	CbGpPWpGaD
Estramustine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00191	CbGpPWpGaD
Estramustine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.00188	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000151	0.00185	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.00015	0.00185	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	0.000149	0.00183	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000143	0.00175	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.00014	0.00172	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	0.000137	0.00168	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000134	0.00164	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000133	0.00163	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000127	0.00155	CbGpPWpGaD
Estramustine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00155	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000125	0.00153	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000117	0.00143	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000112	0.00137	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000111	0.00136	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00011	0.00134	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00011	0.00134	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000107	0.00131	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	9.62e-05	0.00118	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	9.57e-05	0.00117	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	9.49e-05	0.00116	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.22e-05	0.00113	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.16e-05	0.00112	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.1e-05	0.00112	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.85e-05	0.00109	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	8.75e-05	0.00107	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	8.71e-05	0.00107	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	8.14e-05	0.000998	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	8.13e-05	0.000997	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	8.07e-05	0.00099	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.97e-05	0.000977	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.69e-05	0.000943	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.59e-05	0.000931	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.59e-05	0.00093	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	7.35e-05	0.000901	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.07e-05	0.000867	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.97e-05	0.000855	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.94e-05	0.000851	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	6.75e-05	0.000828	CbGpPWpGaD
Estramustine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.7e-05	0.000822	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.69e-05	0.00082	CbGpPWpGaD
Estramustine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.61e-05	0.00081	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	6.39e-05	0.000784	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	6.29e-05	0.000772	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	6.11e-05	0.000749	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.8e-05	0.000711	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	5.64e-05	0.000691	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.6e-05	0.000686	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.39e-05	0.000661	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.24e-05	0.000643	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.68e-05	0.000574	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.5e-05	0.000551	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.3e-05	0.000527	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.22e-05	0.000517	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.09e-05	0.000502	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.02e-05	0.000492	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.8e-05	0.000466	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.57e-05	0.000438	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.54e-05	0.000434	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.51e-05	0.00043	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.47e-05	0.000426	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.23e-05	0.000396	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.14e-05	0.000385	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.08e-05	0.000378	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	3.08e-05	0.000378	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.04e-05	0.000373	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.85e-05	0.00035	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.78e-05	0.000341	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.74e-05	0.000336	CbGpPWpGaD
Estramustine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.7e-05	0.000331	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.56e-05	0.000314	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.55e-05	0.000313	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.13e-05	0.000262	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.11e-05	0.000258	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2e-05	0.000245	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.96e-05	0.000241	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.91e-05	0.000234	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	0.000233	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	0.00023	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.86e-05	0.000228	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.00021	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.7e-05	0.000208	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000193	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.53e-05	0.000188	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.38e-05	0.000169	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	0.000161	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	0.000159	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.26e-05	0.000155	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.26e-05	0.000155	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.24e-05	0.000152	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.21e-05	0.000148	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	0.000148	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.000141	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.04e-05	0.000128	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.52e-06	0.000117	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.79e-06	9.55e-05	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.45e-06	9.14e-05	CbGpPWpGaD
